4 completed, 3 unknown, 1 active not recruiting. 8 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 4, Unknown 3, Active not recruiting 1 |
Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety Eyelid Speculum Retraction, Cotton-Tipped Applicator Retraction - Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema | Not applicable | Active not recruiting | Jakkrit Juhong | 129 | 2026-09-09 | 2026-09-25 |
| Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT) - Polypoidal Choroidal Vasculopathy | Not applicable | Completed | Singapore National Eye Centre | 60 | 2021-02-01 | 2025-11-18 |
| Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept Aflibercept Injection (2 mg/0.05 ml), Defer treatment - Polypoidal Choroidal Vasculopathy | Not applicable | Unknown | Chiang Mai University | 80 | 2020-11-01 | 2021-01-15 |
| Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid Aflibercept Injection - Choroidal Neovascularization, Choroid Disease | Not applicable | Completed | Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | 17 | 2017-09-18 | 2019-09-03 |
| Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment Intravitreal aflibercept - Polypoidal Choroidal Vasculopathy | Not applicable | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 37 | 2014-01-01 | 2017-12-08 |
| Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen verteporfin, verteporfin and ranibizumab - Polypoidal Choroidal Vasculopathy | Not applicable | Completed | Sun Yat-sen University | 60 | 2012-12-01 | 2018-03-08 |
| Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy ranibizumab(Lucentis), verteporfin(Visudyne) - Polypoidal Choroidal Vasculopathy | Not applicable | Unknown | Seoul St. Mary's Hospital | 16 | 2011-02-01 | 2011-05-30 |
| Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy Intravitreal Bevacizumab - Polypoidal Choroidal Vasculopathy | Not applicable | Unknown | Asan Medical Center | 20 | 2006-05-01 | 2006-10-04 |
Choroid Diseases (1) · Choroidal Neovascularization (1) · Patient Satisfaction (1) · Retinal Vein Occlusion (1)
Eye Diseases (8) · Metaplasia (8) · Neovascularization, Pathologic (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Uveal Diseases (8) · Choroid Diseases (7) · Choroidal Neovascularization (7) · Behavior (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Health Behavior (1) · Retinal Diseases (1) · Thrombosis (1) · Treatment Adherence and Compliance (1)
Verteporfin (4) · aflibercept (3) · Injections (1) · Ranibizumab (1)
Asan Medical Center (1) · Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo (1) · Chiang Mai University (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Jakkrit Juhong (1) · Seoul St. Mary's Hospital (1) · Singapore National Eye Centre (1) · Sun Yat-sen University (1)
South Korea (2) · Thailand (2) · China (1) · France (1) · Italy (1) · Singapore (1)
Chenjin Jin, Ph.D. (1) · Gemmy Cheung Chui Ming (1) · Hyewon Chung, MD (1) · Jakkrit Juhong, MD (1) · June-Gone Kim, MD (1) · Martine Mauget-Faysse (1) · Salvatore Cillino, MD PhD (1) · Sun Young Lee, MD (1) · Young Hee Yoon, MD (1)